DENVER, Jan. 7, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, announced today that it will participate in the 37th Annual J.P. Morgan Healthcare Conference being held January 7-10, 2019, at the Westin St. Francis Hotel in San Francisco, CA. Kent Thiry, Chairman and CEO, will be presenting on Monday, January 7, at 5:00 p.m. Pacific Time.
The presentation and subsequent Q&A session will be broadcast live.
To access the presentation live audio broadcast, listeners should go to:
https://jpmorgan.metameetings.net/events/healthcare19/sessions/23870-davita-inc/webcast
To access the Q&A session live audio broadcast, listeners should go to:
https://jpmorgan.metameetings.net/events/healthcare19/sessions/24205-davita-inc-q-a/webcast
The audio will be available for replay via the above link for 90 days following the event.
The slide presentation will be available for download from the events calendar section of the company's investor relations website at:
investors.davita.com
About DaVita Inc.
DaVita Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and DaVita Medical Group. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of Sept. 30, 2018, DaVita Kidney Care operated or provided administrative services at 2,625 outpatient dialysis centers located in the United States serving approximately 201,000 patients. The company also operated 251 outpatient dialysis centers located in 10 countries outside the United States. DaVita Medical Group manages and operates medical groups and affiliated physician networks in California, Colorado, Florida, Nevada, New Mexico and Washington in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. DaVita Medical Group's teammates, employed clinicians and affiliated clinicians provided care for approximately 1.7 million patients. For more information, please visit DaVita.com/About.
Contact Information
Investors:
Jim Gustafson
(310) 536-2585
jim.gustafson@davita.com
SOURCE DaVita Inc.
